About Body Protection Compound-157
A synthetic pentadecapeptide derived from a fragment of human gastric juice protein. Extensive animal research shows wound healing, tendon/ligament repair, gut protection, and anti-inflammatory effects — but ZERO human RCTs have been published as of 2025. All efficacy claims are extrapolated from rodent injection studies. Oral bioavailability in humans is completely uncharacterized. Not FDA-approved for any indication and WADA-banned. Sold as a 'research chemical' — regulatory status is gray-area. Popular in biohacking communities but clinical evidence in humans does not exist.
What Body Protection Compound-157 supports
- Extensive animal data for tissue repair — zero human RCTs
- Not FDA-approved; oral bioavailability in humans unknown
How much Body Protection Compound-157 to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
250–1000
mcg
Supplement doses range 250–1000 mcg/day. No human RCTs exist to establish a therapeutic dose. Animal studies use 10 mcg/kg injected intraperitoneally — oral bioavailability in humans is unknown.
Clinical evidence
Limited clinical evidence. Zero human RCTs — all efficacy data is from rodent injection studies. Oral bioavailability in humans is uncharacterized. Popular but completely unproven in humans.
Examine.com